Trials / Completed
CompletedNCT00273468
To Study the Safety and Effectiveness of a Granisetron Patch to Treat Chemotherapy-Induced Nausea and Vomiting (CINV)
A Randomised, Active Control, Double-blind, Double-dummy, Parallel-group, Multi-national Study to Assess the Efficacy, Tolerability and Safety of the Granisetron Transdermal Delivery System in Chemotherapy-induced Nausea and Vomiting (CINV) Associated With the Administration of Moderately or Highly Emetogenic Multi-day Chemotherapy
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 630 (planned)
- Sponsor
- Kyowa Kirin Co., Ltd. · Industry
- Sex
- All
- Age
- 15 Years
- Healthy volunteers
- Not accepted
Summary
To study the safety and effectiveness of a granisetron patch to treat Chemotherapy-Induced Nausea and Vomiting (CINV)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Granisetron |
Timeline
- Start date
- 2006-01-01
- Completion
- 2006-10-01
- First posted
- 2006-01-09
- Last updated
- 2024-06-17
Source: ClinicalTrials.gov record NCT00273468. Inclusion in this directory is not an endorsement.